KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Free Cash Flow: 2020-2025

Historic Free Cash Flow for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$31.6 million.

  • Ginkgo Bioworks Holdings' Free Cash Flow rose 73.35% to -$31.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$187.2 million, marking a year-over-year increase of 51.66%. This contributed to the annual value of -$382.1 million for FY2024, which is 13.63% down from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' Free Cash Flow is -$31.6 million, which was up 21.56% from -$40.3 million recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Free Cash Flow peaked at -$10.7 million during Q3 2021, and registered a low of -$170.7 million during Q4 2021.
  • For the 3-year period, Ginkgo Bioworks Holdings' Free Cash Flow averaged around -$77.2 million, with its median value being -$77.9 million (2023).
  • Its Free Cash Flow has fluctuated over the past 5 years, first slumped by 368.63% in 2023, then surged by 73.35% in 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Free Cash Flow (Quarterly) stood at -$170.7 million in 2021, then climbed by 23.72% to -$130.2 million in 2022, then spiked by 52.93% to -$61.3 million in 2023, then increased by 8.38% to -$56.1 million in 2024, then surged by 73.35% to -$31.6 million in 2025.
  • Its Free Cash Flow stands at -$31.6 million for Q3 2025, versus -$40.3 million for Q2 2025 and -$59.1 million for Q1 2025.